Adjunctive use of entacapone with LD in PD is beneficial by preventing catechol-O-methyltransferase from breaking down and metabolizing LD, which extends and stabilizes the clinical response to LD (Kaakkola, 2000). This evidence concerns the gene COMT and Parkinson disease.